Metformin and Hepatic Carcinogenesis

Cancer Prevention Research, 04/11/2012

The clinical need to develop novel prevention strategies for hepatoma is obvious, given an increasing prevalence and poor prognosis. The clues that metformin or related biguanides may have utility in this area justify accelerated laboratory research, as more data concerning mechanism, pharmacokinetics, and predictors of efficacy will help to optimize the design of clinical trials.

Print Article Summary Cat 2 CME Report